M. Sonoo et al., N18 in median somatosensory evoked potentials: a new indicator of medullary function useful for the diagnosis of brain death, J NE NE PSY, 67(3), 1999, pp. 374-378
Objectives-To record N18 in median somatosensory evoked potentials (SEPs) f
or deeply comatose or brain dead patients and to demonstrate the usefulness
of N18 for the diagnosis of brain death in comparison with auditory brain
stem responses (ABRs) and P13/14 in median SEPs, which have been convention
ally used as complementary tests for the diagnosis of brain death.
Methods-Subjects were 19 deeply comatose or brain dead patients. Thirteen r
ecordings were performed in deeply comatose but not brain dead conditions,
and 12 recordings were performed in brain death. N18 was evaluated in the C
Pi-C2S lead (or other scalp-C2S leads) to obtain a flat baseline.
Results-N18 was preserved in 12 of 13 non-brain dead comatose recordings wh
ereas it was completely lost for all of the 12 brain death recordings. P13/
14 in median SEPs was preserved for all the comatose recordings, whereas ap
parent P13/14-like potentials, usually of low amplitude, were seen in nine
of 12 brain death recordings-that is, frequent false positives. The ABRs al
ready showed features which were characteristic for brain death (loss of co
mponents other than wave 1 or small wave 2) for four comatose recordings, i
n three of which N18 was preserved. The last result not only corresponds wi
th the fact that ABRs can evaluate pontine and midbrain functions and not m
edullary function, but further supports the medullary origin of N18. In the
four patients followed up for the course of progression from coma to brain
death, N18s preserved in normal size during the comatose state were comple
tely lost after brain death was established.
Conclusions-The N18 potential is generated by the cuneate nucleus in the me
dulla oblongata in the preceding studies. N18 is suggested to be a promisin
g tool for the diagnosis of brain death because there were no false positiv
es and rare false negatives in the present series for detecting the remaini
ng brain stem function.